Literature DB >> 22522920

Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein.

Nathan S Alexander1, Angela Blount, Shaoyan Zhang, Daniel Skinner, Stephen B Hicks, Michael Chestnut, Frederick A Kebbel, Eric J Sorscher, Bradford A Woodworth.   

Abstract

OBJECTIVES/HYPOTHESIS: Evidence indicates that decreased mucociliary clearance (MCC) is a major contributing feature to chronic rhinosinusitis. Tobacco-smoke exposure is thought to inhibit transepithelial Cl(-) secretion, a major determinant of airway surface liquid hydration and MCC. The objective of the current study was to evaluate the effects of acrolein exposure (a prominent tobacco smoke toxin) on vectorial Cl(-) transport through the major apical anion channel cystic fibrosis transmembrane conductance regulator (CFTR) in sinonasal epithelium. STUDY
DESIGN: In vitro investigation.
METHODS: Primary murine nasal septal epithelia (MNSE; wild-type and transgenic CFTR(-/-)) cultures were exposed to acrolein in Ussing chambers and the effects on Cl(-) secretion investigated using pharmacologic manipulation. Cellular cyclic adenosine monophosphate (cAMP) signaling and cytotoxicity were also investigated.
RESULTS: Acrolein stimulated Cl(-) secretion (ΔI(SC) - change in short-circuit current in μA/cm(2)) at concentrations similar to smoker's airways (100 μM, 15.8 ± 2.2 vs. 2.4 ± 0.8 [control]; P < .0001), suppressed forskolin-stimulated C- transport at 300 μM (13.3 ± 1.2 vs. 19.9 ± 1.0; P < .01), and completely abolished all transport at 500 μM (-1.1 ± 1.6). Stimulated Cl(-) secretion was solely reliant upon the presence of CFTR (confirmed in transgenic CFTR(-/-) MNSE), but independent of cAMP signaling. Inhibition at higher concentrations was not secondary to cellular cytotoxicity.
CONCLUSIONS: The present study demonstrates that acrolein has complex but pronounced interaction with the major apical Cl(-) transport mechanism that uses CFTR. Further investigations are required to determine acrolein's impact as a tobacco smoke constituent on mucociliary transport.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522920      PMCID: PMC3548450          DOI: 10.1002/lary.23278

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  25 in total

1.  Confirmations and surprises in the association of tobacco use with sinusitis.

Authors:  J E Lieu; A R Feinstein
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-08

2.  Hesperidin stimulates cystic fibrosis transmembrane conductance regulator-mediated chloride secretion and ciliary beat frequency in sinonasal epithelium.

Authors:  Christopher Azbell; Shaoyan Zhang; Daniel Skinner; James Fortenberry; Eric J Sorscher; Bradford A Woodworth
Journal:  Otolaryngol Head Neck Surg       Date:  2010-09       Impact factor: 3.497

Review 3.  Mucociliary clearance in the airways.

Authors:  A Wanner; M Salathé; T G O'Riordan
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

4.  Tar content and ciliotoxicity of cigarette smoke.

Authors:  T Dalhamn; R Rylander
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

5.  Ciliotoxicity of cigar and cigarette smoke.

Authors:  T Dalhamn; R Rylander
Journal:  Arch Environ Health       Date:  1970-02

6.  Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers.

Authors:  F Verra; E Escudier; F Lebargy; J F Bernaudin; H De Crémoux; J Bignon
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

7.  The bioflavonoid compound, sinupret, stimulates transepithelial chloride transport in vitro and in vivo.

Authors:  Frank Virgin; Shaoyan Zhang; Daniel Schuster; Christopher Azbell; James Fortenberry; Eric J Sorscher; Bradford A Woodworth
Journal:  Laryngoscope       Date:  2010-05       Impact factor: 3.325

8.  Exposure to cigarette smoke condensate reduces calcium activated chloride channel transport in primary sinonasal epithelial cultures.

Authors:  Frank W Virgin; Christopher Azbell; Daniel Schuster; Jumin Sunde; Shaoyan Zhang; Eric J Sorscher; Bradford A Woodworth
Journal:  Laryngoscope       Date:  2010-07       Impact factor: 3.325

9.  Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium.

Authors:  Angela Blount; Shaoyan Zhang; Michael Chestnut; Brian Hixon; Daniel Skinner; Eric J Sorscher; Bradford A Woodworth
Journal:  Laryngoscope       Date:  2011-08-16       Impact factor: 3.325

10.  Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction.

Authors:  J P Eiserich; A van der Vliet; G J Handelman; B Halliwell; C E Cross
Journal:  Am J Clin Nutr       Date:  1995-12       Impact factor: 7.045

View more
  22 in total

1.  Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of Pseudomonas sinusitis.

Authors:  Dong-Jin Lim; Justin McCormick; Daniel Skinner; Shaoyan Zhang; Jeffrey B Elder; John G McLemore; Mark Allen; John Martin West; Jessica W Grayson; Steven M Rowe; Bradford A Woodworth; Do-Yeon Cho
Journal:  Int Forum Allergy Rhinol       Date:  2019-12-23       Impact factor: 3.858

2.  Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.

Authors:  Bradford A Woodworth
Journal:  Laryngoscope       Date:  2015-05-06       Impact factor: 3.325

3.  Correlation of T2R38 taste phenotype and in vitro biofilm formation from nonpolypoid chronic rhinosinusitis patients.

Authors:  Nithin D Adappa; Carl M Truesdale; Alan D Workman; Laurel Doghramji; Corrine Mansfield; David W Kennedy; James N Palmer; Beverly J Cowart; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2016-06-16       Impact factor: 3.858

4.  Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis.

Authors:  Do-Yeon Cho; Daniel Skinner; Calvin Mackey; Harold B Lampkin; Jeffrey Brent Elder; Dong Jin Lim; Shaoyan Zhang; Justin McCormick; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-18       Impact factor: 3.858

5.  Cystic fibrosis transmembrane conductance regulator activation by the solvent ethanol: implications for topical drug delivery.

Authors:  Do-Yeon Cho; Daniel Skinner; Shaoyan Zhang; James Fortenberry; Eric J Sorscher; Nichole R Dean; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-03       Impact factor: 3.858

6.  Assessment of acquired mucociliary clearance defects using micro-optical coherence tomography.

Authors:  Kiranya E Tipirneni; Jessica W Grayson; Shaoyan Zhang; Do-Yeon Cho; Daniel F Skinner; Dong-Jin Lim; Calvin Mackey; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2017-06-28       Impact factor: 3.858

7.  Ion transport mechanisms for smoke inhalation-injured airway epithelial barrier.

Authors:  Jianjun Chang; Zaixing Chen; Runzhen Zhao; Hong-Guang Nie; Hong-Long Ji
Journal:  Cell Biol Toxicol       Date:  2020-06-25       Impact factor: 6.691

8.  Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.

Authors:  S Vamsee Raju; Patricia L Jackson; Clifford A Courville; Carmel M McNicholas; Peter A Sloane; Gina Sabbatini; Sherry Tidwell; Li Ping Tang; Bo Liu; James A Fortenberry; Caleb W Jones; Jeremy A Boydston; J P Clancy; Larry E Bowen; Frank J Accurso; J Edwin Blalock; Mark T Dransfield; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

Review 9.  Will chronic e-cigarette use cause lung disease?

Authors:  Temperance R Rowell; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-25       Impact factor: 5.464

Review 10.  Risk Factors and Comorbidities in Chronic Rhinosinusitis.

Authors:  Derrick Tint; Stephanie Kubala; Elina Toskala
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.